Norton Pulmonary Specialists Research & Clinical Trials | Norton Healthcare Louisville, Ky.

Norton Pulmonary Specialists Research & Clinical Trials

Norton Pulmonary Specialists is at the forefront of pulmonary treatment research. As investigators on numerous trials, our specialist physicians have unparalleled experience with many innovative treatments once they are approved for broad use. Patients also may be eligible to take part in these experimental pulmonary treatments. Norton Pulmonary Specialists researchers also contribute to groundbreaking studies and other publications in peer-reviewed journals.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Pulmonary Clinical Trials and Studies

Idiopathic Pulmonary Fibrosis (IPF)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 In Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
NCRG@nortonhealthcare.org
Sponsor: Nitto Denko Corporation

Lung Surgery

HUMANITARIAN USE DEVICE: The Spiration® Valve System Protocol# H060002
Study Type: Device Study
Tanya Wiese D.O.
Tanya Wiese D.O.
Principal Investigator
Norton Heart & Vascular Institute
Recently published research
Sponsor: Spiration, Inc

Obstructive Sleep Apnea (OSA)

Investigational Plan for Pivotal THN Study #3 (aura6000 Targeted Hypoglossal Neurostimulation System)
Study Type: Device Study
David Winslow M.D.
David Winslow, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
NCRG@nortonhealthcare.org
Sponsor: LivaNova, USA, Inc

Oral Appliance

Randomized, Open Label Clinical Trial of an Oral Appliance to Reduce Snoring
Study Type: Device Study
David Winslow M.D.
David Winslow, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
ncrg@nortonhealthcare.org
Sponsor: Delta Dental

PAH

RiOciguAt UseRs Registry – The ROAR registry
Study Type: Registry
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Sponsor: Bayer Healthcare Pharmaceuticals

Pulmonary Arterial Hypertension

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-Label Extension (ADVANCE-extension)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: UNITED THERAPEUTICS CORPORATION

Pulmonary Arterial Hypertension

Pulmonary Hypertension Association Registry (PHAR)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: Pulmonary Hypertension Association (PHA)

Pulmonary Arterial Hypertension

A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults with Pulmonary Arterial Hypertension
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Sponsor: Merck Sharp & Dohme CORP

Pulmonary Arterial Hypertension

Retrospective Evaluation of Pulmonary Arterial Hypertension (PAH) Patients: Real-World Experience from the Trio Health Network
Study Type: Registry
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Sponsor: Actelion Pharmaceuticals US, Inc

Pulmonary Arterial Hypertension

An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: Gossamer Bio, Inc.

Pulmonary Arterial Hypertension

A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Sponsor: Altavant Sciences, Inc.

Pulmonary Arterial Hypertension (PAH)

A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: UNITED THERAPEUTICS CORPORATION

Pulmonary Arterial Hypertension (PAH)

A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients with Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
Sponsor: Actelion/Janssen

Pulmonary Embolism

FLowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH)
Study Type: Registry
Daniel Rothschild M.D.
Daniel Rothschild M.D.
Principal Investigator
Norton Heart & Vascular Institute
Eligibility Criteria and Other Details
cvresearch@nortonhealthcare.org
Sponsor: Inari Medical Inc

Pulmonary Hypertension

A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: UNITED THERAPEUTICS CORPORATION

Pulmonary Hypertension

An Open-Label Extension study of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: UNITED THERAPEUTICS CORPORATION

Pulmonary Hypertension

A Randomized, Double-Blind, Placebo-Controlled Dose Escalation And Verification Clinical Study To Assess The Safety And Efficacy Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects At Risk Of Pulmonary Hypertension Associated With Pulmonary Fibrosis On Long Term Oxygen Therapy (Part 1 And Part 2)
Study Type: Drug Study
John McConnell M.D.
John McConnell, M.D.
Principal Investigator
Norton Pulmonary Specialists
Recently published research
Eligibility Criteria and Other Details
npsresearch@nortonhealthcare.org
Sponsor: Bellerophon Pulse Technologies LLC

Recent Research Published by Norton Pulmonary Specialists Physicians

RSS (Norton Clinical Research Group[Affiliation]) OR (Kentuckiana Pulmonary[Affiliation]) OR (Norton Pulmonary Specialists[Affiliation])

Read More at Pubmed.gov

Pulmonary – 5864

Appointments

(502) 559-5864

Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Chronic fatigue treatment starts by ruling out other causes of your symptoms

Treating chronic fatigue syndrome (also known as myalgic encephalomyelitis or ME/CFS) starts with getting the right diagnosis. According to the Centers for Disease Control and Prevention, about 90% of those with chronic fatigue aren’t diagnosed, […]

Read Full Story

The sleep apnea and stroke connection

Snoring loudly is a telltale sign of obstructive sleep apnea and a warning you may face a higher risk of stroke. Sleep apnea more than doubles the risk of stroke for middle-aged and older men [...]

Read Full Story

More crazy, scary dreams? Welcome to coronavirus pandemic dreams

Isolation, anxiety and a nonstop barrage of grim news about the coronavirus pandemic are a perfect storm for vivid dreams — and nightmares. According to David H. Winslow Jr., M.D., pulmonologist and sleep medicine specialist […]

Read Full Story

Consider these changes before turning to melatonin

Some people who have trouble falling asleep try melatonin supplements to boost levels of the hormone, which already is produced by the body. Sold over the counter in pill and liquid forms, laboratory-made melatonin is […]

Read Full Story

Hot flashes, sleep apnea causes of menopause-related sleep issues

Menopause is a time of major hormonal, physical and psychological changes for women, and those changes can have an impact on sleep. During the time before menopause, called perimenopause, the ovaries decrease production of estrogen […]

Read Full Story
View All Stories
Related Stories

Chronic fatigue treatment starts by ruling out other causes of your symptoms

Treating chronic fatigue syndrome (also known as myalgic encephalomyelitis or ME/CFS) starts with getting the right diagnosis. According to the Centers for Disease Control and Prevention, about 90% of those with chronic fatigue aren’t diagnosed, […]

Read Full Story

The sleep apnea and stroke connection

Snoring loudly is a telltale sign of obstructive sleep apnea and a warning you may face a higher risk of stroke. Sleep apnea more than doubles the risk of stroke for middle-aged and older men [...]

Read Full Story

More crazy, scary dreams? Welcome to coronavirus pandemic dreams

Isolation, anxiety and a nonstop barrage of grim news about the coronavirus pandemic are a perfect storm for vivid dreams — and nightmares. According to David H. Winslow Jr., M.D., pulmonologist and sleep medicine specialist […]

Read Full Story

Consider these changes before turning to melatonin

Some people who have trouble falling asleep try melatonin supplements to boost levels of the hormone, which already is produced by the body. Sold over the counter in pill and liquid forms, laboratory-made melatonin is […]

Read Full Story

Hot flashes, sleep apnea causes of menopause-related sleep issues

Menopause is a time of major hormonal, physical and psychological changes for women, and those changes can have an impact on sleep. During the time before menopause, called perimenopause, the ovaries decrease production of estrogen […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.